Dexcom is making more friends. Already having partnerships with Animas and Omnipod, Dexcom has now signed a research and development agreement with Roche Diagnostics U.S. The plan is to integrate Dexcom's continuous glucose monitor into Roche's insulin pumps so you can see trends and blood glucose data in one handheld device.
Here's an excerpt from the announcement:
A continuous glucose monitor reveals short-term trends in the blood sugar as they happen. The monitor reads out a constant stream of glucose data every 1 to 5 minutes. You can see the direction your blood sugar is taking in the last 1, 3, 6, 9, 12, or 24 hours, depending on what times your specific monitor offers. This gives 288 to 1440 readings a day compared to the 4 to 8 fingerstick readings you rely on with a meter.
Diabetes care has improved with many of the technological advances in the field. From improvements in insulin pumps and infusion sets to the implementation of continuous glucose monitors, technology is helping deal with diabetes easier than ever before. More technology companies are getting involved in diabetes everyday. In this section, you will find information on: